Companies /Healthcare

Codexis Inc

NASDAQ: CDXS Biotechnology
$1.48
▼ $0.04 (−2.32%) today
Markets closed · 12:26am ET
Today · % change

Fundamentals

Market Cap
$165.4M
Profit Margin
-39.6%
Revenue (TTM)
$77.7M
EPS (TTM)
$-0.29
52-Week Range
$1 – $3
Street Target
$6.33

About Codexis

Codexis Inc specializes in discovering, developing, and selling enzymes and proteins for various applications. With a focus on biocatalysts, the company offers products and services that enhance the efficiency and productivity of manufacturing processes, particularly in the pharmaceutical sector. Codexis is known for its CodeEvolver technology platform, which aids in developing advanced biocatalysts. Additionally, it collaborates with entities like Nestlé Health Science on specific health treatments. Based in Redwood City, California, Codexis markets its innovations primarily in the United States and Europe.

CDXS Coverage

1:20pm ET
Investing

Green Energy Avoids Tumble Off Fiscal Cliff

Any tax legislation worth the name carries with it a host of hangers on that represent special gifts to special interests. The American Taxpayer Relief Act of 2012 is no different. Here…

Paul Ausick